toggle visibility Search & Display Options

Select All    Deselect All
 | 
Citations
 | 
   print
Rosager, A. M., Sorensen, M. D., Dahlrot, R. H., Boldt, H. B., Hansen, S., Lathia, J. D., et al. (2017). Expression and prognostic value of JAM-A in gliomas. J Neurooncol, .
toggle visibility
Voss, D. M., Spina, R., Carter, D. L., Lim, K. S., Jeffery, C. J., & Bar, E. E. (2017). Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression. Sci Rep, 7(1), 4292.
toggle visibility
Gravina, G. L., Mancini, A., Colapietro, A., Vitale, F., Vetuschi, A., Pompili, S., et al. (2017). The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models. Tumour Biol, 39(6), 1010428317695528.
toggle visibility
Liu, Y., Shen, Y., Sun, T., & Yang, W. (2017). Mechanisms regulating radiosensitivity of glioma stem cells. Neoplasma, 64(5), 655–665.
toggle visibility
Goncalves, D. P. N., Rodriguez, R. D., Kurth, T., Bray, L. J., Binner, M., Jungnickel, C., et al. (2017). Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures. Acta Biomater, 58, 12–25.
toggle visibility
Select All    Deselect All
 | 
Citations
 | 
   print